CE14 - Physiologie et physiopathologie

Neuro-Immune contribution of Toxoplasma gondii to the progression of Alzheimer's Disease pathology – NinTenDo

Submission summary

Alzheimer's disease (AD) is a multifactorial disease for which several molecular and functional abnormalities are now well known. Among these, neuronal excitotoxicity on neurons leads to synaptic loss and build-up of DNA double-strand breaks (DSB) that drive neurodegeneration and cognitive decline. A role for adaptative immunity, and inflammation due to chronically activated microglia has been suggested as a trigger and regulator of AD, but the neuroimmune interplay that underlies neuronal excitotoxicity and dysfunction remains ill-defined and is certainly diverse. As a common neurotropic brain-persisting pathogen, which infection is tightly controlled by specific immune responses, the parasite Toxoplasma gondii (Tg) may impact on the progression of AD. Supporting this hypothesis, our interdisciplinary consortium has gathered preliminary data showing aggravation of Tau pathology, inflammation dominated by Il-1b signaling and earlier onset of cognitive decline in models of Tauopathy or amyloidosis infected by latent Tg. We have also shown the instrumental role of DSB on spatial memory deficits promoted by Tg. In our project NinTenDo, our overarching goal is to decipher the molecular mechanisms and determinants that promote the progression of AD pathology in the brain of two Tg-infected transgenic mouse strains, modeling the two major lesional determinants of AD, i.e., tauopathy and amyloidogenesis. Our specific aims will be i) to identify specific neuro-immune signatures induced by chronic Tg infection in AD brains, with specific correlation with AD outcome progression; ii) to evaluate the specific contribution of neuronal vs. microglial IL-1b signaling to Tg-induced progression of AD pathology. Overall, this project will allow to decipher mechanisms that may link AD to pathogen persistence in the brain, and will improve our understanding on new regulatory mechanisms of neuro-immune pathophysiology of cognitive decline.

Project coordination

Elsa Suberbielle (Institut national de la sante et de la recherche medicale)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partner

INFINITy Institut national de la sante et de la recherche medicale
Inserm
Institut national de la sante et de la recherche medicale
INFINITy Institut national de la sante et de la recherche medicale

Help of the ANR 703,574 euros
Beginning and duration of the scientific project: January 2023 - 48 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter